Crystal form B of lurasidone hydrochloride and preparation method thereof

A technique for the crystal form of alkanediimide hydrochloride, which is applied to the crystal form B of lurasidone hydrochloride and its preparation field, and can solve problems such as crystal forms of compounds not mentioned

Active Publication Date: 2013-10-23
SHANGHAI INST OF PHARMA IND CO LTD +2
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene- Butyl]-(1'R, 2'S, 3'R, 4'S)-2,3-bicyclo[2,2,1]heptane diimide hydrochloride, but the application did not mention and the crystal form of the compound
[0005] N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene- Butyl]-(1'R, 2'S, 3'R, 4'S)-2,3-bicyclo[2,2,1]heptane diimide hydrochloride, but the application did not mention And the crystal form of the compound, only mentioning that the melting point of the compound is 215°C-217°C

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Crystal form B of lurasidone hydrochloride and preparation method thereof
  • Crystal form B of lurasidone hydrochloride and preparation method thereof
  • Crystal form B of lurasidone hydrochloride and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] 10g N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene-butyl]- (1'R, 2'S, 3'R, 4'S)-2,3-bicyclo[2,2,1]heptane diimide hydrochloride was added to a mixed solution of 100mL acetone and 36mL water, heated to 40 ℃ dissolve clear, cooling. The obtained solution was left to stand, and the solid was precipitated by filtration, and dried to obtain 5.9 g of a white solid. The obtained product was identified as Form B by X-ray powder diffraction.

Embodiment 2

[0031] 10g N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene-butyl]- Add (1'R, 2'S, 3'R, 4'S)-2,3-bicyclo[2,2,1]heptanediimide hydrochloride into 300mL acetone, heat to reflux until dissolved, and continue heating for 1h ,cool down. The resulting solution was stirred overnight, filtered, and dried to obtain 6.8 g of a white solid. The obtained product was identified as Form B by X-ray powder diffraction.

Embodiment 3

[0033] 10g N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene-butyl]- Add (1'R, 2'S, 3'R, 4'S)-2,3-bicyclo[2,2,1]heptanediimide hydrochloride into 200mL methanol, heat to reflux until dissolved, and continue heating for 1h ,cool down. The resulting solution was stirred overnight, filtered, and dried to obtain 6.9 g of a white solid. The obtained product was identified as Form B by X-ray powder diffraction.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
decomposition temperatureaaaaaaaaaa
melting pointaaaaaaaaaa
Login to view more

Abstract

The invention discloses a crystal form B of N-[4-[4-(1,2-benzisothiazole-3-yl)-1-piperazine]-(2R, 3R)-2,3-tetramethylene-butyl]-(1'R, 2'S, 3'R, 4'S)-2,3-bicyclo[2,2,1], which is characterized in that the crystal form B displays an X-ray powder diffraction pattern having characteristic peaks represented by 2 theta degrees, namely 8.5+ / -0.2, 8.8+ / -0.2, 11.4+ / -0.2, 13.8+ / -0.2, 14.9+ / -0.2, 15.4+ / -0.2, 16.4+ / -0.2, 17.0+ / -0.2, 17.3+ / -0.2, 17.7+ / -0.2, 18.7+ / -0.2, 19.1+ / -0.2, 19.4+ / -0.2, 20.7+ / -0.2, 21.2+ / -0.2, 21.9+ / -0.2, 27.7+ / -0.2, 33.1+ / -0.2, and 35.9+ / -0.2.

Description

technical field [0001] The present invention relates to N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene-butyl New crystal of ]-(1'R, 2'S, 3'R, 4'S)-2,3-bicyclo[2,2,1]heptane diimide hydrochloride (lurasidone hydrochloride) Form B and process for its preparation. Background technique [0002] Compound of formula (1) N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene -Butyl]-(1'R, 2'S, 3'R, 4'S)-2,3-bicyclo[2,2,1]heptane diimide hydrochloride (common name lurasidone hydrochloride Salt) is a central nervous system drug, suitable for the treatment of schizophrenia and bipolar disorder. [0003] [0004] N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene- Butyl]-(1'R, 2'S, 3'R, 4'S)-2,3-bicyclo[2,2,1]heptane diimide hydrochloride, but the application did not mention and the crystal form of the compound. [0005] N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene- Butyl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D417/12
Inventor 张华王胡博朱雪焱袁哲东魏哲鹏
Owner SHANGHAI INST OF PHARMA IND CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap